TITLE

Prostatic acid phosphatase

AUTHOR(S)
Romslo, I
PUB. DATE
February 1971
SOURCE
British Medical Journal;2/13/1971, Vol. 1 Issue 5745, p406
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
64099307

 

Related Articles

  • Radioimmunoassay of serum prostatic acid phosphatase in prostatic cancer.  // British Medical Journal;9/9/1978, Vol. 2 Issue 6139, p719 

    Reports on the development of a radioimmunoassay for the detection of the serum prostatic acid phosphatase. Use of biochemical estimation of enzymes; Specification of radioimmunoassay in diagnosing prostatic cancer; Problems in biochemical testings.

  • ACID PHOSPHATASE, PROSTATIC  // Davis's Comprehensive Handbook of Laboratory & Diagnostic Tests ;Jan2006, p3 

    Acid phosphatases are enzymes found in many tissues, including the prostate gland, bone, spleen, liver, and kidney, as well as in red blood cells and platelets. Seminal fluid also contains high concentrations of acid phosphatase, and detection of this enzyme in vaginal swabs or from other...

  • Low-dose difluoromethylornithine and polyamine levels in human prostate tissue. Messing, Edward M.; Love, Richard R.; Messing, E M; Love, R R; Tutsch, K D; Verma, A K; Douglas, J; Pomplun, M; Simsiman, R; Wilding, G // JNCI: Journal of the National Cancer Institute;08/18/99, Vol. 91 Issue 16, p1416 

    Features a study on the effects of difluoromethylornithine on human peripheral zone prostatic ornithine decarboxylate activities and polyamine levels in patients undergoing open prostatic surgery. Measurement of testosterone, prostate-specific antigen, and prostatic acid phosphatase levels;...

  • Tumour markers in breast cancer.  // British Medical Journal;4/21/1979, Vol. 1 Issue 6170, p1036 

    Examines the uses of tumor markers in the routine management of some types of cancer. Measurement on the serum acid phosphatase concentrations; Diagnosis of prostatic carcinoma; Estimation of monoclonal globulin.

  • Novel vaccine well-tolerated for refractory PCa. Dosa, Laszlo // Urology Times;Jul2002, Vol. 30 Issue 7, p10 

    Explores the effectiveness of the vaccine APC8015 in hormone-refractory prostate cancer patients. Design of the vaccine to stimulate cell-mediated immunity against prostate acid phosphatase; Psychological advantage of the therapy.

  • Chronic prostatitis may have autoimmune component. Tennant, Scott // Urology Times;Apr2001, Vol. 29 Issue 4, p12 

    Focuses on the autoimmune component of chronic prostatitis in the United States. Role of autoimmunity in chronic prostatitis; Use of seminal plasma as antigen to attract T-cell response; Analysis of the peripheral blood mononuclear cells for PSA response, prostatic acid phosphatase and...

  • Identification and characterization of regulatory elements of the human prostatic acid phosphate promoter. Zelivianski, Stanislav; Igawa, Tsukasa; Lim, Stephen; Taylor, Rodney; Ming-Fong Lin // Oncogene;5/23/2002, Vol. 21 Issue 23, p3696 

    Presents a study that cloned and characterized the promoter region of prostatic acid phosphatase (PAcP) to gain insight into the regulation of PAcP. Description of PAcP; Genes whose expression is restricted to prostate cells; Comparison of the functional activity of PAcP promoter in human...

  • Molecular Bandit Keeps Pain at Bay.  // BioWorld Today;8/9/2010, Vol. 21 Issue 152, Special section p1 

    This article discusses a study by researchers at the University of North Carolina at Chapel Hill published in the current issue of the "Journal of Neuroscience" which examined the inhibitory effect of prostatic acid phosphatases on pain.

  • CORRESPONDENCE. Vallance, S.; Sanderson, C.; Komrower, G.M.; Harvey, D.R.; McCloy, E.C.; Kane, Stephen; Jones, F. Avery; Keele, K.D.; Finlay, A.Y.; Statham, B.; Knight, A.G.; Nyberg, Gunnar; Davidson, A.C.; Smith, S.E.; Smail, Peter; Crow, T.J.; Booth, C.C.; Carr, A.K. // British Medical Journal (Clinical Research Edition);5/23/1981, Vol. 282 Issue 6277, p1702 

    Presents several correspondence related to medicine. Effects of rectal examination on serum prostatic acid phosphatase; Issue on direct chemical injury to the esophagus by impacted tablets or capsules; Hazards of the long-term use of antacids for duodenal cancers.

  • Old serum marker for prostate cancer may get new life. Bankhead, Charles // Urology Times;Jan97, Vol. 25 Issue 1, p6 

    Reports that prostatic acid phosphatase (PAP) may have value as a prognostic marker after radical prostatectomy according to a retrospective analysis. PAP's association with prostate cancer; Analysis of pretreatment PAP results for patients who underwent radical prostatectomy; Reverse...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics